Serum Villin‐1—A Novel Marker of Gut Barrier Damage in Acutely Decompensated Cirrhosis: A Cohort Study and Validation
Dávid Tornai(Beth Israel Deaconess Medical Center), Mária Papp(University of Debrecen), Joan Clària(European Foundation for the Study of Chronic Liver Failure), András Budai(Semmelweis University), Tamás Dinya(University of Debrecen), Florian A. Rosenberger(Max Planck Institute of Biochemistry), Jonel Trebicka(Klinik für Schlafmedizin), Minneke J. Coenraad(Leiden University Medical Center), Boglárka Balogh(University of Debrecen), Wim Laleman(University Hospital Münster), Ferrán Aguilar(European Foundation for the Study of Chronic Liver Failure), Péter Antal‐Szalmás(University of Debrecen), András Kiss(Semmelweis University), Anikó Csillag(University of Debrecen), Nóra Sipeki(University of Debrecen), Zsuzsanna Vitális(Semmelweis University), István Tornai(University of Debrecen), Lukács Baráth(University of Debrecen), Gábor Méhes(University of Debrecen), Richard Moreau(Mizoram University), Attila Enyedi(University of Debrecen), Tamás Tornai(University of Debrecen)
Cited by 4
Related Papers
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites
|Journal of Hepatology|2015|864
Severe sepsis in cirrhosis†
|Hepatology|2009|446
Experimental liver fibrosis research: update on animal models, legal issues and translational aspects
|Fibrogenesis & Tissue Repair|2013|330